Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-02-01

著者

• Dahut William

  Medical Oncology Branch Center For Cancer Research National Cancer Institute

• Figg William

  Medical Oncology Branch Center For Cancer Research National Cancer Institute

• Gardner Erin

  Clinical Pharmacology Program Saic-frederick Inc.

• GARDNER Erin

  Clinical Pharmacology Program, SAIC-Frederick Inc.

関連論文

• Determination of the antiangiogenesis agent 2-methoxyestradiol in human plasma by liquid chromatography with ultraviolet detection
• Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment
• Determination of 17-dimethylaminoethylamino-17-demethoxygeldanamycin in human plasma by liquid chromatography with mass-spectrometric detection
• Determination of SU5416, a novel angiogenesis inhibitor, in human plasma by liquid chromatography
• Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometry
• Determination of a benzamide histone deacetylase inhibitor, MS-275, in human plasma by liquid chromatography with mass-spectrometric detection
• Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detection

スポンサーリンク